ClinicalTrials.Veeva

Menu

Efficacy of Osimertinib in Patients With Lung Cancer

H

Hunan Province Tumor Hospital

Status

Enrolling

Conditions

Advanced Non-Small Cell Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT06174857
EGFR 19 delins

Details and patient eligibility

About

This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients must be ≥18 years.
  • Provision of fully informed consent prior to any study specific procedures.
  • Advanced or metastatic lung squamous cell carcinoma confirmed by histology or cytology.
  • According to the RECIST 1.1 standard, the patient must have at least one measurable lesion.

Exclusion criteria

  • None

Trial contacts and locations

1

Loading...

Central trial contact

Yongchang C Zhang, MD; Nong Yang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems